Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Gefitinib can cause scalp skin issues and permanent hair loss.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Basal cell carcinoma cases are rising globally.

Basal cell carcinoma cases are rising globally.

Trichoepitheliomas and some basal cell carcinomas likely come from hair follicle stem cells.

Basal cell carcinoma may start from parts of tiny hair follicles.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Basal cell carcinomas likely originate from hair follicle cells or stem cells.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

CXCR2 in skin cells promotes tumor growth.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Dermabrasion improves skin appearance by removing the top layer to promote healing.

Understanding molecular processes in skin development is key to creating targeted treatments for skin disorders.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The author now believes tricholemmal carcinoma is a rare type of infundibular squamous cell carcinoma and more research is needed on these tumors.

The PML protein helps prevent skin cancer in mice.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

A man with a skin nodule was diagnosed with a rare skin condition called cutaneous focal mucinosis, which can be confused with other skin cancers.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Increasing SSAT makes skin more prone to cancer.

PEH in vulvar LS is common and needs careful diagnosis to avoid confusion with cancer.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.